CG
RNAM

Carmignac Gestion’s Avidity Biosciences RNAM Stock Holding History

Carmignac Gestion’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,938
Closed -$4.18M – 141
2025
Q4 		$4.18M Buy
+57,938
New +$3.74M 0.06% 78

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Carmignac Gestion's RNAM Position: Q1 2026 in Review

Carmignac Gestion sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 57,938 shares — an estimated $4.18M sold.

Carmignac Gestion first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $4.18M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Carmignac Gestion reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Carmignac Gestion sold 57,938 Avidity Biosciences shares in Q1 2026, an estimated $4.18M.
  • Carmignac Gestion first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Carmignac Gestion's Avidity Biosciences position peaked at $4.18M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Carmignac Gestion's 13F filing for Q1 2026, filed 15 Jun 2026.